These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24353336)

  • 1. Effect of subthalamic nucleus deep brain stimulation on driving in Parkinson disease.
    Buhmann C; Maintz L; Hierling J; Vettorazzi E; Moll CK; Engel AK; Gerloff C; Hamel W; Zangemeister WH
    Neurology; 2014 Jan; 82(1):32-40. PubMed ID: 24353336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
    Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
    Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.
    Wolz M; Hauschild J; Koy J; Fauser M; Klingelhöfer L; Schackert G; Reichmann H; Storch A
    Parkinsonism Relat Disord; 2012 Sep; 18(8):994-7. PubMed ID: 22682974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease.
    Silveri MC; Ciccarelli N; Baldonero E; Piano C; Zinno M; Soleti F; Bentivoglio AR; Albanese A; Daniele A
    Neuropsychologia; 2012 Jul; 50(8):1980-9. PubMed ID: 22575085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease.
    Aman JE; Abosch A; Bebler M; Lu CH; Konczak J
    Mov Disord; 2014 Feb; 29(2):221-8. PubMed ID: 24243788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
    Lyons KE; Davis JT; Pahwa R
    Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitch variability in patients with Parkinson's disease: effects of deep brain stimulation of caudal zona incerta and subthalamic nucleus.
    Karlsson F; Olofsson K; Blomstedt P; Linder J; van Doorn J
    J Speech Lang Hear Res; 2013 Feb; 56(1):150-8. PubMed ID: 23165974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.
    Dec-Ćwiek M; Tutaj M; Gracies JM; Volkmann J; Rudzińska M; Słowik A; Szczudlik A
    Neurol Neurochir Pol; 2017; 51(5):354-360. PubMed ID: 28669542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could deep brain stimulation help with driving for patients with Parkinson's?
    Buhmann C; Gerloff C
    Expert Rev Med Devices; 2014 Sep; 11(5):427-9. PubMed ID: 24930934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa and subthalamic deep brain stimulation responses are not congruent.
    Zaidel A; Bergman H; Ritov Y; Israel Z
    Mov Disord; 2010 Oct; 25(14):2379-86. PubMed ID: 20824733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.